Sanofi-Aventis - Database of Clinical Trials by Pharmaceutical Companies

Paid Clinical Trials and Focus Groups


Find Paid Clinical Trials

Paid Clinical Trials - : Sanofi-Aventis

Top of Directory » All Categories » by Company » Sanofi-Aventis



  • Self Titration With Apidra to Reach Target Study (START)

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: insulin glargine;   Drug: Apidra (insulin glulisine)
    Sponsor:   Sanofi-Aventis
    Recruiting - verified November 2009
  • Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

    Condition:   Influenza
    Interventions:   Biological: Influenza Virus Vaccine USP Trivalent Types A and B;   Biological: Influenza Virus Vaccine USP Trivalent Types A and B;   Biological: Influenza Virus Vaccine USP Trivalent Types A and B;   Biological: Influenza Virus Vaccine USP Trivalent Types A and B
    Sponsor:   Sanofi-Aventis
    Active, not recruiting - verified November 2009
  • An International Randomized Trial of Trans-radial Versus Trans-femoral PCI Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy

    Conditions:   Acute Coronary Syndrome;   Percutaneous Coronary Intervention
    Intervention:   Procedure: Percutaneous Coronary Intervention
    Sponsors:   Population Health Research Institute;   Co-sponsor: Sanofi-Aventis
    Recruiting - verified November 2009
  • A Multiple-dose Study of the Safety and Tolerability of REGN88 in Rheumatoid Arthritis Subjects

    Condition:   Rheumatoid Arthritis
    Intervention:   Biological: REGN88
    Sponsors:   Regeneron Pharmaceuticals;   Sanofi-Aventis
    Completed - verified November 2009
  • Ascending Dose Study of the Safety and Tolerability of REGN668 in Normal Healthy Volunteers

    Condition:   Healthy
    Intervention:   Biological: REGN668
    Sponsors:   Regeneron Pharmaceuticals;   Sanofi-Aventis
    Recruiting - verified November 2009
  • Single Injection of REGN475/SAR164877 in Treatment of Vertebral Fracture Pain

    Condition:   Back Pain
    Interventions:   Drug: REGN475/SAR164877;   Drug: Placebo
    Sponsors:   Sanofi-Aventis;   Regeneron Pharmaceuticals
    Not yet recruiting - verified October 2009
  • Single Injection of RGN475/SAR164877 in the Treatment of Chronic Pancreatitis Pain

    Condition:   Abdominal Pain Upper
    Interventions:   Drug: RGN475/SAR164877;   Drug: Placebo
    Sponsors:   Sanofi-Aventis;   Regeneron Pharmaceuticals
    Not yet recruiting - verified October 2009
  • Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor

    Condition:   Neoplasms, Malignant
    Interventions:   Drug: cabazitaxel (XRP6258);   Drug: gemcitabine;   Drug: midazolam
    Sponsor:   Sanofi-Aventis
    Not yet recruiting - verified October 2009
  • Conjugate And Polysaccharide Vaccines Compared With Polysaccharide Vaccine In Hiv-Infected Adults

    Conditions:   Pneumococcal Vaccines;   HIV;   HIV Infections
    Intervention:   Biological: Prevenar and Pneumo23
    Sponsors:   Hospital Universitari Son Dureta;   Hospital Son Llatzer;   Fondo de Investigacion Sanitaria
    Recruiting - verified October 2009
  • Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers

    Conditions:   Encephalitis;   Japanese Encephalitis
    Intervention:  
    Sponsor:   Sanofi-Aventis
    Enrolling by invitation - verified October 2009
    • Menu
    Find Paid Clinical Trials